UNRESECTABLE CLINICAL STAGE III MERKEL CELL CARCINOMA AJCC V8

Clinical trials for UNRESECTABLE CLINICAL STAGE III MERKEL CELL CARCINOMA AJCC V8 explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE CLINICAL STAGE III MERKEL CELL CARCINOMA AJCC V8 trials appear

Sign up with your email to follow new studies for UNRESECTABLE CLINICAL STAGE III MERKEL CELL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Triple-Threat treatment tested for tough skin cancer

Disease control Ongoing

This study is testing a combination of three immunotherapy drugs for patients with advanced Merkel cell carcinoma, a rare and aggressive skin cancer, that has spread and stopped responding to a common first-line treatment. The drugs are designed to work together to reactivate the…

Matched conditions: UNRESECTABLE CLINICAL STAGE III MERKEL CELL CARCINOMA AJCC V8

Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control

Last updated Apr 02, 2026 04:26 UTC

UNRESECTABLE CLINICAL STAGE III MERKEL CELL CARCINOMA AJCC V8

Get alerted when new UNRESECTABLE CLINICAL STAGE III MERKEL CELL CARCINOMA AJCC V8 trials appear

New Triple-Threat treatment tested for tough skin cancer